The efficacy and safety of monopolar radiofrequency for treatment of enlarged pores in Asia
Phase 4
Recruiting
- Conditions
- Patients with visible enlarged poresmonopolar radiofrequency, enlarged pores
- Registration Number
- TCTR20220213001
- Lead Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
1. aged 18-60 years
2. were diagnosed with enlarged pores by two dermatologists
Exclusion Criteria
1. Patients who are pregnant, lactating, and postpartum within 1 year 2. Patients who taking oral isotretinoin
3. Patients with other skin diseases, or having infection at the area of face
4. Immunocompromised patients
5. Patients with hypertrophic scar or keloid
6. Patients with history of Cushing syndrome or Ehlers-Danlos syndrome
7. Patients with cancers or skin cancers
8. Patients with mental disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pore sizes by Antera Baseline, 1, 2, 4, 7 months Antera,Pore sizes by ImageJ Baseline, 1, 2, 4, 7 months ImageJ
- Secondary Outcome Measures
Name Time Method Sebum level Baseline, 1, 2, 4, 7 months Sebumeter,Safety Baseline, 1, 2, 4, 7 months Adverse event,Physician improvement scale Baseline, 1, 2, 4, 7 months percent improvement,Patient improvement scale Baseline, 1, 2, 4, 7 months percent improvement